Released Feb 25, 2021, after the close
10-K filed Feb 25, 2021, 56 days after period end · 0001636422-21-000026
Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$53.28M$53.28M derived+22.5% vs Q4 2019+12.9% vs Q3 2020
Net Income-$43.02M-$43.02M derivedN/M vs Q4 2019N/M vs Q3 2020
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$38,922,000N/M
Operating Cash Flowderived-$4,141,000N/M
Free Cash Flowderived-$10,596,000N/M
Margins · derived
Operating margin-73.1%−41.6 pt vs Q4 2019
Net margin-80.7%−47.9 pt vs Q4 2019
What the release said
The release
Same quarter
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|
| Revenue | $53.28M | $43.50M | — |
| Net Income | -$43.02M | -$14.27M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR